239 related articles for article (PubMed ID: 31970414)
21. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
22. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
23. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
24. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
25. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
Zavadil J; Cermak L; Soto-Nieves N; Böttinger EP
EMBO J; 2004 Mar; 23(5):1155-65. PubMed ID: 14976548
[TBL] [Abstract][Full Text] [Related]
26. Sirt7-dependent inhibition of cell growth and proliferation might be instrumental to mediate tissue integrity during aging.
Vakhrusheva O; Braeuer D; Liu Z; Braun T; Bober E
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():201-12. PubMed ID: 19261981
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
28. Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells.
Moon SU; Kang MH; Sung JH; Kim JW; Lee JO; Kim YJ; Lee KW; Bang SM; Lee JS; Kim JH
Oncol Rep; 2015 Jan; 33(1):185-92. PubMed ID: 25370208
[TBL] [Abstract][Full Text] [Related]
29. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Hsieh CL; Ma HP; Su CM; Chang YJ; Hung WY; Ho YS; Huang WJ; Lin RK
Life Sci; 2016 Apr; 151():7-14. PubMed ID: 26926079
[TBL] [Abstract][Full Text] [Related]
30. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
32. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
33. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
34. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
[TBL] [Abstract][Full Text] [Related]
35. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53.
Boudreau HE; Ma WF; Korzeniowska A; Park JJ; Bhagwat MA; Leto TL
Oncotarget; 2017 Jul; 8(27):44379-44397. PubMed ID: 28574838
[TBL] [Abstract][Full Text] [Related]
36. TGF-beta and cancer: is Smad3 a repressor of hTERT gene?
Li H; Xu D; Toh BH; Liu JP
Cell Res; 2006 Feb; 16(2):169-73. PubMed ID: 16474430
[TBL] [Abstract][Full Text] [Related]
37. SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling.
Lee HJ; Yun CH; Lim SH; Kim BC; Baik KG; Kim JM; Kim WH; Kim SJ
Oncogene; 2007 Jan; 26(2):173-85. PubMed ID: 16819512
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4.
Park Y; Kim W; Lee JM; Park J; Cho JK; Pang K; Lee J; Kim D; Park SW; Yang KM; Kim SJ
Oncogene; 2015 Sep; 34(39):5037-45. PubMed ID: 25531329
[TBL] [Abstract][Full Text] [Related]
39. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
40. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]